Brief: Oncocyte Reports Third Quarter 2022 Financial Results
Nov 10 (Reuters) - Oncocyte Corp OCX.O :
* ONCOCYTE REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* Q3 REVENUE $1.0 MILLION
* QTRLY NET LOSS PER SHARE: BASIC AND DILUTED $0.08
* Q3 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
* Q3 REVENUE VIEW $1.5 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9TDZDJ
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission